[HTML][HTML] Severe allergic reactions to the COVID-19 vaccine–statement and practical consequences

J Kleine-Tebbe, L Klimek, E Hamelmann… - Allergologie …, 2021 - ncbi.nlm.nih.gov
On December 10, 2020, the BBC reported two allergic adverse events following the first
injection of the BioNTech COVID-19 vaccine BNT162b2. Up to December 19, 2020, severe …

ARIA‐EAACI statement on severe allergic reactions to COVID‐19 vaccines–an EAACI‐ARIA position paper

L Klimek, M Jutel, CA Akdis, J Bousquet, M Akdis… - Allergy, 2021 - Wiley Online Library
Further to the approval of the Coronavirus disease 2019 (COVID‐19) vaccine BNT162b2,
several severe anaphylaxis cases occured within the first few days of public vaccination. An …

Severe allergic reactions after COVID-19 vaccination with the Pfizer/BioNTech vaccine in Great Britain and USA: position statement of the German allergy societies …

L Klimek, N Novak, E Hamelmann, T Werfel… - Allergo journal …, 2021 - Springer
Two employees of the National Health Service (NHS) in England developed severe allergic
reactions following administration of BNT162b2 vaccine against COVID-19 (coronavirus …

Allergy to COVID-19 vaccines: a current update

B Cabanillas, N Novak - Allergology International, 2021 - jstage.jst.go.jp
abstract Adverse allergic reactions due to the administration of the vaccines developed for
the protection of coronavirus disease 2019 (COVID-19) have been reported since the …

[HTML][HTML] COVID-19 vaccine-associated anaphylaxis: a statement of the World Allergy Organization Anaphylaxis Committee

PJ Turner, IJ Ansotegui, DE Campbell… - World Allergy …, 2021 - Elsevier
Vaccines against COVID-19 (and its emerging variants) are an essential global intervention
to control the current pandemic situation. Vaccines often cause adverse events; however …

COVID-19 vaccine testing & administration guidance for allergists/immunologists from the Canadian Society of Allergy and Clinical Immunology (CSACI)

TK Vander Leek, ES Chan, L Connors… - Allergy, Asthma & …, 2021 - Springer
Background Safe and effective vaccines provide the first hope for mitigating the devastating
health and economic impacts resulting from coronavirus disease 2019 (COVID-19) and …

EAACI statement on the diagnosis, management and prevention of severe allergic reactions to COVID‐19 vaccines

M Sokolowska, T Eiwegger, M Ollert, MJ Torres… - Allergy, 2021 - Wiley Online Library
The first approved COVID‐19 vaccines include Pfizer/BioNTech BNT162B2, Moderna
mRNA‐1273 and AstraZeneca recombinant adenoviral ChAdOx1‐S. Soon after approval …

Who is really at risk for anaphylaxis due to COVID-19 vaccine?

M Caminati, G Guarnieri, G Senna - Vaccines, 2021 - mdpi.com
The vaccination campaign against the Severe acute respiratory syndrome coronavirus 2
(Sars-Cov-2) started on 8 December 2020 in UK, after the approval of BNT162b2 by the …

Allergic reactions to the coronavirus disease 2019 vaccine (ARCOV) study: the McGill University Health Centre experience

F ALMuhizi, M Fein, S Gabrielli, L Gilbert… - Annals of Allergy …, 2022 - Elsevier
Background Messenger RNA coronavirus disease 2019 (COVID-19) vaccines have been
associated with allergic reactions. A history of anaphylaxis has been suggested as a risk …

Rapid progress in our understanding of COVID-19 vaccine allergy: a cause for optimism, not hesitancy

A Banerji, AE Norton, KG Blumenthal… - Journal of Allergy and …, 2022 - Elsevier
Anaphylaxis is a life-threatening condition and when associated with vaccination, leads to
vaccine hesitancy. The concerns around vaccine-related anaphylaxis have become even …